Therapeutic Genome Editing in Cardiovascular Diseases

A variety of genetic cardiovascular diseases may one day be curable using gene editing technology. Germline genome editing and correction promises to permanently remove monogenic cardiovascular disorders from the offspring and subsequent generations of affected families. Although technically feasibl...

Descripción completa

Detalles Bibliográficos
Autores principales: German, David M., Mitalipov, Shoukhrat, Mishra, Anusha, Kaul, Sanjiv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
STATE-OF-THE-ART REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390678/
https://www.ncbi.nlm.nih.gov/pubmed/30847427
http://dx.doi.org/10.1016/j.jacbts.2018.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390678/
https://www.ncbi.nlm.nih.gov/pubmed/30847427
http://dx.doi.org/10.1016/j.jacbts.2018.11.004

Ejemplares similares